UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications

Sleep medicine, 2020-04, Vol.68, p.97-109

2020

Volltextzugriff (PDF)

Shift work and the assessment and management of shift work disorder (SWD)

Sleep medicine reviews, 2013-02, Vol.17 (1), p.41-54

2013

Volltextzugriff (PDF)

Dosing Optimization of Low-Sodium Oxybate in Narcolepsy and Idiopathic Hypersomnia in Adults: Consensus Recommendations

Neurology and therapy, 2024-06, Vol.13 (3), p.785-807

2024

Volltextzugriff (PDF)

From Bench to Bedside: An Overview of Rotigotine for the Treatment of Restless Legs Syndrome

Clinical therapeutics, 2014-03, Vol.36 (3), p.436-455

Bogan, Richard K., MD

2014

Volltextzugriff (PDF)

Use of blood biomarkers to screen for obstructive sleep apnea

Nature and science of sleep, 2018-01, Vol.10, p.159-167

2018

Volltextzugriff (PDF)

Long-term Maintenance Treatment of Restless Legs Syndrome With Gabapentin Enacarbil: A Randomized Controlled Study

Mayo Clinic proceedings, 2010-06, Vol.85 (6), p.512-521

2010

Volltextzugriff (PDF)

Effects of oxybate dose and regimen on disrupted nighttime sleep and sleep architecture

Sleep medicine, 2024-02, Vol.114, p.255-265

2024

Volltextzugriff (PDF)

Evaluation of the Effect of JZP-110 in Patients with Narcolepsy Assessed Using the Maintenance of Wakefulness Test Censored to 20 Minutes

Sleep medicine, 2017-07, Vol.35, p.12-16

2017

Volltextzugriff (PDF)

Clinical considerations for the diagnosis of idiopathic hypersomnia

Sleep medicine reviews, 2022-12, Vol.66, p.101709-101709, Article 101709

2022

Volltextzugriff (PDF)

Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study

Lancet neurology, 2022-01, Vol.21 (1), p.53-65

2022

Volltextzugriff (PDF)

Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy

Sleep (New York, N.Y.), 2021-03, Vol.44 (3), p.1

2021

Volltextzugriff (PDF)

Long-Term Safety and Tolerability During a Clinical Trial and Open-Label Extension of Low-Sodium Oxybate in Participants with Narcolepsy with Cataplexy

CNS drugs, 2023-04, Vol.37 (4), p.323-335

2023

Volltextzugriff (PDF)

Safety and pharmacodynamics of a single infusion of danavorexton in adults with idiopathic hypersomnia

Sleep (New York, N.Y.), 2023-09, Vol.46 (9), p.1

2023

Volltextzugriff (PDF)

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Armodafinil for Excessive Sleepiness Associated With Jet Lag Disorder

Mayo Clinic proceedings, 2010-07, Vol.85 (7), p.630-638

2010

Volltextzugriff (PDF)

Long-term efficacy and safety of tonic motor activation for treatment of medication-refractory restless legs syndrome: A 24-Week Open-Label Extension Study

Sleep (New York, N.Y.), 2023-10, Vol.46 (10), p.1

2023

Volltextzugriff (PDF)

The National Veteran Sleep Disorder Study: Descriptive Epidemiology and Secular Trends, 2000-2010

Sleep (New York, N.Y.), 2016-07, Vol.39 (7), p.1399-1410

2016

Volltextzugriff (PDF)

Safety and pharmacodynamics of a single infusion of danavorexton in adults with obstructive sleep apnea experiencing excessive daytime sleepiness despite adequate use of CPAP

Sleep medicine, 2023-07, Vol.107, p.229-235

2023

Volltextzugriff (PDF)

Efficacy and safety of tonic motor activation (TOMAC) for medication-refractory restless legs syndrome: a randomized clinical trial

Sleep (New York, N.Y.), 2023-10, Vol.46 (10), p.1

2023

Volltextzugriff (PDF)

Recommendations for clinical management of excessive daytime sleepiness in obstructive sleep apnoea – A Delphi consensus study

Sleep medicine, 2023-12, Vol.112, p.104-115

2023

Volltextzugriff (PDF)

Effect of oral JZP-110 (ADX-N05) treatment on wakefulness and sleepiness in adults with narcolepsy

Sleep medicine, 2015-09, Vol.16 (9), p.1102-1108

2015

Volltextzugriff (PDF)

Time to response with sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy

Journal of clinical sleep medicine, 2015-04, Vol.11 (4), p.427-432

2015

Volltextzugriff (PDF)

Changes in Cataplexy Frequency in a Clinical Trial of Lower-Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications

CNS drugs, 2022-06, Vol.36 (6), p.633-647

2022

Volltextzugriff (PDF)

Long-term efficacy and safety of low-sodium oxybate in an open-label extension period of a placebo-controlled, double-blind, randomized withdrawal study in adults with idiopathic hypersomnia

Journal of clinical sleep medicine, 2023-10, Vol.19 (10), p.1811-1822

2023

Volltextzugriff (PDF)

Getting Serious about Excessive Sleepiness

Sleep health, 2019-08, Vol.5 (4), p.319-319

Bogan, Richard K.

2019

Volltextzugriff (PDF)

Low-sodium oxybate improved symptoms in adults with narcolepsy with cataplexy: a plain language summary of publication

Future neurology, 2024-01, Vol.18 (4)

2024

Volltextzugriff (PDF)

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(90)

Publikationsform

Sprache

Englisch
(110)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications

Shift work and the assessment and management of shift work disorder (SWD)

Dosing Optimization of Low-Sodium Oxybate in Narcolepsy and Idiopathic Hypersomnia in Adults: Consensus Recommendations

From Bench to Bedside: An Overview of Rotigotine for the Treatment of Restless Legs Syndrome

Use of blood biomarkers to screen for obstructive sleep apnea

Long-term Maintenance Treatment of Restless Legs Syndrome With Gabapentin Enacarbil: A Randomized Controlled Study

Effects of oxybate dose and regimen on disrupted nighttime sleep and sleep architecture

Evaluation of the Effect of JZP-110 in Patients with Narcolepsy Assessed Using the Maintenance of Wakefulness Test Censored to 20 Minutes

Clinical considerations for the diagnosis of idiopathic hypersomnia

Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study

Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy

Long-Term Safety and Tolerability During a Clinical Trial and Open-Label Extension of Low-Sodium Oxybate in Participants with Narcolepsy with Cataplexy

Safety and pharmacodynamics of a single infusion of danavorexton in adults with idiopathic hypersomnia

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Armodafinil for Excessive Sleepiness Associated With Jet Lag Disorder

Long-term efficacy and safety of tonic motor activation for treatment of medication-refractory restless legs syndrome: A 24-Week Open-Label Extension Study

The National Veteran Sleep Disorder Study: Descriptive Epidemiology and Secular Trends, 2000-2010

Safety and pharmacodynamics of a single infusion of danavorexton in adults with obstructive sleep apnea experiencing excessive daytime sleepiness despite adequate use of CPAP

Efficacy and safety of tonic motor activation (TOMAC) for medication-refractory restless legs syndrome: a randomized clinical trial

Recommendations for clinical management of excessive daytime sleepiness in obstructive sleep apnoea – A Delphi consensus study

Effect of oral JZP-110 (ADX-N05) treatment on wakefulness and sleepiness in adults with narcolepsy

Time to response with sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy

Changes in Cataplexy Frequency in a Clinical Trial of Lower-Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications

Long-term efficacy and safety of low-sodium oxybate in an open-label extension period of a placebo-controlled, double-blind, randomized withdrawal study in adults with idiopathic hypersomnia

Getting Serious about Excessive Sleepiness

Low-sodium oxybate improved symptoms in adults with narcolepsy with cataplexy: a plain language summary of publication

Suchergebnisse filtern